The company produces iron nanoparticles and also focuses on the development of new environmental applications of Fe(0) nanoparticles, study of their effective stabilization and reactivity with selected pollutants.
The company was founded for the purpose of research and development of new therapies for the treatment of specific and hitherto incurable forms of leukaemia. Its business is the production, research and development of targeted pharmaceuticals based on nanoparticle structures.
The group is involved in the rapidly developing field of nanobiopharmacy. It focuses on tissue engineering (e.g. scaffolds for cartilage and skin replacement, differentiation of stem cells into chondrocytes), wound healing, gene therapy and targeted drug delivery (using above mentioned polysaccharides and their conjugates). The research and innovation is an integral part of the company activities. Due to recent investments in the state-of-the art laboratory equipment and experienced and motivated scientists the company creates a unique center for regenerative medicine research, including various in-vitro and in-vivo tests.
TTS has experience in development and deposition of thin film sputtered layers, in circuit design and thin film layers applications in hybrid IC's, HCMOS IC's, sensors, and precise resistive networks technologies.
The company's mission is to commercialize innovative materials, products and processes based on nanotechnology, which are result of research and technology
development of laboratories in the Czech Republic and abroad.
Nanotechnology research organizations in Czech Republic